AspirEx is a medical device company, founded in 2014 by a team of international clinically experienced physicians and engineers. AspirEx develops innovative, proprietary, and therapeutic medical devices and solutions to improve patients’ quality of life from incidents and prevalence of diseases.

AspirEx’s innovative Vocal Implant System (VOIS) is a solution for treatment of glottis insufficiency. The particular shape of the implant enables a precise adjustment of the VOIS implant, improving voice quality, swallowing and preventing complications from glottis insufficiency. It is the first thyroplasty implant in the market that can be adjusted both intra- and postoperatively. The postoperative implant adjustments can be easily and noninvasively performed, which make it possible to optimize individual needs without revision surgery.

AspirEx is dedicated to providing minially invasive and innovative ENT technologies for voice disorders, which are patient-orientated, physician friendly and improve the quality of lives around the world.